Table: Modalis Therapeutics - 6-MTH group results

Modalis Therapeutics

07/08/2025 07:36

Aug 7 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Dec 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Operating       loss 1.03         loss 838 mln                  
  Recurring       loss 1.02         loss 780 mln                  
  Net             loss 1.02         loss 780 mln                  
  EPS          loss 13.78 yen      loss 21.98 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T